Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep 23;122(38):e2507028122.
doi: 10.1073/pnas.2507028122. Epub 2025 Sep 16.

Intercellular propagation of RIPK1/RIPK3 amyloid fibrils

Affiliations

Intercellular propagation of RIPK1/RIPK3 amyloid fibrils

Yeyang Ma et al. Proc Natl Acad Sci U S A. .

Erratum in

Abstract

The canonical necrosome formed by receptor-interacting protein kinase 1 (RIPK1) and RIPK3 is a functional amyloid fibril structure critical to intracellularly drive necroptosis. Since necroptosis leads to the release of intracellular content, the fate of RIPK1/RIPK3 fibrils after necroptotic cell death has not been investigated. Here, we tracked RIPK1 and RIPK3 coassemblies and found that these fibrillar aggregates could be released into the culture medium after the membrane rupture in necroptotic cells. Interestingly, these RIPK1/RIPK3 fibrils were capable of infiltrating recipient cells and acting as seeds for the nucleation and formation of the endogenous necrosome. Cryo electron microscopy structural analysis unveiled a distinctive S-shaped conformation common to RHIM fibrils of RIPK1 and RIPK3, which can facilitate the cross-seeding of RIPK3 by RIPK1 or RIPK1/RIPK3 fibrils. Our findings suggest the ability of functional RIPK1/RIPK3 amyloid fibrils in intercellular spreading to induce protein conformation change in recipient cells and provide structural insights into the mechanism of RIPK1 and RIPK3 cross-templating to drive necroptosis.

Keywords: RIPK1; RIPK3; amyloid; necroptosis; necrosome.

PubMed Disclaimer

Conflict of interest statement

Competing interests statement:The authors declare no competing interest.

References

    1. Yuan J., Ofengeim D., A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379–395 (2023), 10.1038/s41580-023-00689-6. - DOI - PubMed
    1. Caccamo A., et al. , Necroptosis activation in Alzheimer’s disease. Nat. Neurosci. 20, 1236–1246 (2017). - PubMed
    1. Ito Y., et al. , RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353, 603–608 (2016). - PMC - PubMed
    1. Yuan J., Amin P., Ofengeim D., Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases. Nat. Rev. Neurosci. 20, 19–33 (2019). - PMC - PubMed
    1. Xu D., Zou C., Yuan J., Genetic regulation of RIPK1 and necroptosis. Annu. Rev. Genet. 55, 235–263 (2021). - PubMed

MeSH terms

Substances

LinkOut - more resources